R. E. E. Ahmad, E. E. M. A. Elatief, W. H. A. K. El Sayed, R. R. Ali, E. M. Ashour, M. Y. A. Abdelsamee
International Journal of Physiotherapy and Research, Vol 6(4):2797-05, 2018
Background: Temporomandibular joint dysfunctions (TMJDs) are considered the most common chronic orofacial pain condition characterized by pain in the temporomandibular joint (TMJ) area, masticatory muscles and associated musculoskeletal structures with the affection of mouth opening. Conventional therapy and low-level laser therapy (LLLT) are safe and noninvasive modalities that each therapist focuses on to relieve pain and increase function.
Objective: The purpose of this study was to investigate the effect of conventional therapy and low-level laser therapy on pain and limitations of daily functions in patients with temporomandibular joint dysfunction (TMJD).
Methods: Sixty patients (45 females and 15 males) with myofascial pain syndrome of TMJ were divided
randomly into study and control groups. The study group received conventional therapy consisting of active and stretching exercises for mandibular muscles with ultrasound and LLLT application on TMJ area. Control group received conventional therapy only. Pressure pain threshold was evaluated using hand-held pressure algometer and pain-related limitations in daily functions were evaluated by the limitations in daily functions-temporomandibular disorders questionnaire (LDF-TMDQ) at baseline and 4 weeks after the treatment.
Results: There was a significant decrease (p < 0.05) in limitations in daily functions, with a significant increase (p < 0.05) in pressure pain threshold for TMJ, masseter and anterior temporalis muscles at both sides in the study group compared with control group.
Conclusion: The combination of conventional therapy with LLLT was more effective in pain relief and improvement of limitations in daily functions than does conventional therapy alone for patients with temporomandibular joint dysfunctions.
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.